All eyes on a hurdle race for a SARS-CoV-2 vaccine

Nature

19 October 2020 - Leading COVID-19 vaccine candidates have progressed through laboratory tests at record speed. 

Two early clinical trials suggest that immunisation delivers a favourable immune response and safety profile, but questions remain.

Read Nature article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Regulation , Timelines , Vaccine , FDA , COVID-19